RxDoctor Payments Data

John McNamara

Pediatric Pulmonology · Minneapolis, MNNPI 1821099466

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,565 of the $2,580 with a category attached, or 99.4%. Vertex accounts for 99.4% of it on its own, with 1 other manufacturer making up the rest.

$2,580in general payments, 2019–2025

Across 2 payments — averaging $1289.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$3K
  • GSK$15
$563,773in research payments, 2019–2025

Across 26 payments — averaging $21,684 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$560K
  • AbbVie$2K
  • Vivus LLC$1K

What the payments were for

  • Consulting fees$2,56599%
  • Food & beverage$151%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vertex1$2,565
GSK1$15

How this compares

Too few pediatric pulmonology providers in Minnesotato place this figure against a meaningful peer group, so we don't.

Other pediatric pulmonology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →